It is called a targeted therapy since it precisely targets the CD38 that are overexpressed around the multiple myeloma cells. Daratumumab is from a class of medicines known as CD38 monoclonal antibodies. Evaluate the full affected individual medication information and talk about this information and any thoughts you may have https://johnnyaoyir.wikijournalist.com/5308881/a_review_of_osimertinib_tagrisso